Single and Combined Impact of Semaglutide, Tirzepatide, and Metformin on β-Cell Maintenance and Function Under High-Glucose–High-Lipid Conditions: A Comparative Study
International Journal of Molecular Sciences · 06.01.2025 · 26 (1) · 421
DOI: 10.3390/ijms26010421 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.01.2025. Verfasst von Esmaeel Ghasemi Gojani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada. Hauptthemen laut MEDLINE: Metformin, Glucagon-Like Peptides, Insulin-Secreting Cells, Glucose. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mitacs.
Abstract (Originalsprache)
Type 2 diabetes (T2D), the most common form, is marked by insulin resistance and β-cell failure. β-cell dysfunction under high-glucose–high-lipid (HG-HL) conditions is a key contributor to the progression of T2D. This study evaluates the comparative effects of 10 nM semaglutide, 10 nM tirzepatide, and 1 mM metformin, both alone and in combination, on INS-1 β-cell maintenance and function under HG-HL conditions. INS-1 cells were pretreated for 2 h with single doses of metformin (1 mM), semaglutide (10 nM), tirzepatide (10 nM), or combinations of 1 mM metformin with either 10 nM semaglutide or 10 nM tirzepatide, followed by 48 h of HG-HL stimulation. The results indicate that combining 1 mM metformin with either 10 nM semaglutide or 10 nM tirzepatide significantly enhances the effects of 10 nM semaglutide and 10 nM tirzepatide on HG-HL-induced apoptosis and dysregulated cell cycle. Specifically, the combination treatments demonstrated superior restoration of glucose-stimulated insulin secretion (GSIS) functionality compared to 1 mM metformin, 10 nM semaglutide, and 10 nM tirzepatide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada.
ORCID-Profile: Esmaeel Ghasemi Gojani, Bo Wang, Igor Kovalchuk
Förderung
- Mitacs
Zitieren
APA
Gojani, E. G., Wang, B., Li, D., Kovalchuk, O., & Kovalchuk, I. (2025). Single and Combined Impact of Semaglutide, Tirzepatide, and Metformin on β-Cell Maintenance and Function Under High-Glucose–High-Lipid Conditions: A Comparative Study. International Journal of Molecular Sciences, 26(1), 421. https://doi.org/10.3390/ijms26010421
Vancouver
Gojani EG, Wang B, Li D, Kovalchuk O, Kovalchuk I. Single and Combined Impact of Semaglutide, Tirzepatide, and Metformin on β-Cell Maintenance and Function Under High-Glucose–High-Lipid Conditions: A Comparative Study. International Journal of Molecular Sciences. 2025;26(1):421. doi:10.3390/ijms26010421
BibTeX
@article{Gojani2025,
author = {Gojani, Esmaeel Ghasemi and Wang, Bo and Li, Dongping and Kovalchuk, Olga and Kovalchuk, Igor},
title = {Single and Combined Impact of Semaglutide, Tirzepatide, and Metformin on β-Cell Maintenance and Function Under High-Glucose–High-Lipid Conditions: A Comparative Study},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {1},
pages = {421},
doi = {10.3390/ijms26010421}
}
EUVIMED